ArticleAnalytical and bioanalytical chemistry2026
Reflection-enhanced LIF for improved label-free classification of blood inflammation with complementary LIBS validation.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study introduces a reflection-enhanced laser-induced fluorescence (RELIF) technique for label-free classification of inflammation severity across three levels in blood serum. RELIF overcomes key limitations of conventional laser-induced fluorescence (LIF), particularly low fluorescence sensitivity and the prozone effect, which are frequently encountered in traditional immunoassays. In RELIF, a cuvette with a reflective surface facing the incident laser beam is used to amplify the diode-laser-pumped fluorescence signal by a factor substantially greater than in standard LIF. In parallel, complementary laser-induced breakdown spectroscopy (LIBS) measurements were performed on dried serum samples using a Q-switched Nd:YAG laser to verify elemental differences among the inflammation classes. RELIF delivered enhanced spectral resolution and sensitivity, yielding approximately 1.30× to 1.53× higher fluorescence signals than conventional LIF. While standard LIF showed reduced performance, especially for samples with severe inflammation, RELIF clearly distinguished all inflammation classes, capturing subtle spectral variations and achieving higher signal-to-noise ratios. Notably, RELIF correctly identified severe inflammation as the class with the weakest fluorescence signal, thereby avoiding the false negatives associated with the prozone phenomenon without the need for sample dilution. LIBS analysis further supported class separation through differences in Ca atomic and CN molecular emissions. Multivariate analysis using partial least squares regression (PLSR) and partial least squares discriminant analysis (PLS-DA) demonstrated high predictive accuracy and robust discrimination. Model performance was further assessed using receiver operating characteristic (ROC) curves; the RELIF-based model outperformed LIF, achieving an area under the curve (AUC) of 0.94 compared with 0.84 for LIF, indicating strong classification performance. Overall, the combined RELIF-LIBS strategy offers a rapid, cost-effective, and non-destructive tool for inflammation classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.